Central Nervous System Agents Used as Trypanosoma cruzi Infection Chemotherapy: Phenothiazines and Related Compounds
Journal:
Current Medicinal Chemistry - Anti-Infective Agents
Volume:
2
Page:
323-333
Author(s):
P. Paglini-Oliva and H. W. Rivarola
NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
323-334
Author(s):
Miao-Kun Sun
Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2349-2365
Author(s):
Ho-Sam Ahn, Samuel Chackalamannil, George Boykow, Michael P. Graziano and Carolyn Foster
Potential New Targets for Antithrombotic Therapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2367-2374
Author(s):
A. Gruber and S. R. Hanson
Coronary Risk Factors in the Elderly: Their Interactions and Treatment
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2465-2478
Author(s):
Pierugo Carbonin, Giuseppe Zuccala, Emanuele Marzetti and Maria Rita Lo Monaco
Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Journal:
Current Drug Targets
Volume:
4
Page:
613-618
Author(s):
Motokuni Aoki, Ryuichi Morishita and Toshio Ogihara
Role of Heme Oxygenase-1 in Cardiovascular Function
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2479-2487
Author(s):
Mark A. Perrella and Shaw-Fang Yet
AMPA Glutamate Receptors and Neuropathic Pain
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
757-763
Author(s):
Susana Morales-Alcelay, Laura Rubio and Ana Martinez
Bradykinin Antagonists as Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2036-2042
Author(s):
J. M. Stewart
Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2197-2206
Author(s):
James M. Scheiman